v3.25.2
Segment Reporting - Significant expenses (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Segment Reporting            
Revenue     $ 22,625   $ 14,720 $ 27,618
Cost of revenue     (490,361)   (48) (693,388)
Gross Profit     (467,736)   14,672 (665,770)
Research and Development:            
Salaries and benefits $ 424,032   1,752,197   844,032 3,757,798
Non-cash stock based compensation expenses 157,291   232,154   221,968 438,740
Facilities expenses 62,432   278,134   133,269 446,573
Direct clinical and non-clinical expenses 16,263   722,126   88,920 1,336,305
Other expenses 14,560   69,255   34,302 114,405
Supplies and materials     1,249,597   25,130 2,309,784
Depreciation expense     293,710     625,169
Research and development 674,578   4,597,173   1,347,621 9,028,774
Selling, General and Administrative:            
Non-cash stock based compensation 5,516,363   308,902   5,731,314 648,548
Professional fees 1,164,039   637,619   2,173,425 1,529,661
Salaries and benefits 371,513   1,497,747   863,493 2,983,915
Insurance expense 209,000   210,582   423,457 429,716
Investor relations 140,948   115,983   259,635 228,624
Director fees and expense 97,500   101,875   195,000 213,750
Other expenses 68,275   350,004   181,482 425,805
Facilities expense 83,263   122,307   166,419 248,954
Sales and marketing 15,066   263,340   37,087 449,568
Travel, lodging and meals 12,737   150,476   19,714 237,483
Selling, general and administrative 7,678,704   3,758,835   10,051,026 7,396,024
Reacquisition of license rights     2,864,600     4,864,600
Total Expense 8,353,282   11,220,608   11,398,647 21,289,398
Loss from Operations (8,353,282)   (11,688,344)   (11,383,975) (21,955,168)
Other segment income (expense) (337,637)   634,645   (790,477) (20,632)
Total Other Income (Expense) (337,637)   634,645   (790,477) (20,632)
Net Income (Loss) (8,690,919) $ (3,483,533) (11,053,699) $ (10,922,101) (12,174,452) (21,975,800)
Corporate and Reconciling Items            
Selling, General and Administrative:            
Non-cash stock based compensation 5,190,000       5,190,000  
Salaries and benefits 10,000       10,000  
Travel, lodging and meals 2,383       2,383  
Selling, general and administrative 5,202,383       5,202,383  
Total Expense 5,202,383       5,202,383  
Loss from Operations (5,202,383)          
Net Income (Loss) (5,202,383)       (5,202,383)  
Ophthalmic Technology | Operating Segments            
Segment Reporting            
Revenue     22,625   14,720 27,618
Cost of revenue     (490,361)   (48) (693,388)
Gross Profit     (467,736)   14,672 (665,770)
Research and Development:            
Salaries and benefits 424,032   1,752,197   844,032 3,757,798
Non-cash stock based compensation expenses 157,291   232,154   221,968 438,740
Facilities expenses 62,432   278,134   133,269 446,573
Direct clinical and non-clinical expenses 16,263   722,126   88,920 1,336,305
Other expenses 14,560   69,255   34,302 114,405
Supplies and materials     1,249,597   25,130 2,309,784
Depreciation expense     293,710     625,169
Research and development 674,578   4,597,173   1,347,621 9,028,774
Selling, General and Administrative:            
Non-cash stock based compensation 326,363   308,902   541,314 648,548
Professional fees 1,164,039   637,619   2,173,425 1,529,661
Salaries and benefits 361,513   1,497,747   853,493 2,983,915
Insurance expense 209,000   210,582   423,457 429,716
Investor relations 140,948   115,983   259,635 228,624
Director fees and expense 97,500   101,875   195,000 213,750
Other expenses 68,275   350,004   181,482 425,805
Facilities expense 83,263   122,307   166,419 248,954
Sales and marketing 15,066   263,340   37,087 449,568
Travel, lodging and meals 10,354   150,476   17,331 237,483
Selling, general and administrative 2,476,321   3,758,835   4,848,643 7,396,024
Reacquisition of license rights     2,864,600     4,864,600
Total Expense 3,150,899   11,220,608   6,196,264 21,289,398
Loss from Operations (3,150,899)   (11,688,344)   (6,181,592) (21,955,168)
Other segment income (expense) (337,637)   634,645   (790,477) (20,632)
Total Other Income (Expense) (337,637)   634,645   (790,477) (20,632)
Net Income (Loss) $ (3,488,536)   $ (11,053,699)   $ (6,972,069) $ (21,975,800)
Segment reporting Other segment expenses and losses include interest income, interest expense, gain (loss) on extinguishment of debt and change in fair value of equity consideration.   Other segment expenses and losses include interest income, interest expense, gain (loss) on extinguishment of debt and change in fair value of equity consideration.   Other segment expenses and losses include interest income, interest expense, gain (loss) on extinguishment of debt and change in fair value of equity consideration. Other segment expenses and losses include interest income, interest expense, gain (loss) on extinguishment of debt and change in fair value of equity consideration.